Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
  1. 4 Grant or award Chief Financial Officer acquired 46,781 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale Director sold 274,000 shares at $28.43 ($7,790,943)
  4. 4 Open-market sale See Remarks sold 2,490 shares at $28.10 ($69,979)
  5. 4 Open-market sale See Remarks sold 10,000 shares at $29.85 ($298,450)
  6. 4 Open-market sale General Counsel sold 4,100 shares at $29.33 ($120,257)
  7. 4 Open-market sale General Counsel sold 3,576 shares at $29.84 ($106,701)
  8. 4 Open-market sale See Remarks sold 7,132 shares at $29.84 ($212,805)
  9. 4 Open-market sale See Remarks sold 3,238 shares at $29.84 ($96,615)
  10. 4 Grant or award Chief Medical Officer acquired 11,096 shares (grant or award)
  11. 4 Open-market sale CEO sold 20,272 shares at $29.84 ($604,876)
  12. 4 Option exercise CEO acquired 46,828 shares (option exercise)
  13. 4 Option exercise See Remarks acquired 26,189 shares (option exercise)
  14. 4 Option exercise General Counsel acquired 9,712 shares (option exercise)
  15. 4 Option exercise See Remarks acquired 6,274 shares (option exercise)
  16. 4 Open-market sale See Remarks sold 638 shares at $27.20 ($17,356)
  17. 4 Option exercise See Remarks acquired 1,586 shares (option exercise)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale Director sold 20,000 shares at $22.53 ($450,646)

Page 8 of 21 · 406 filings